Skip to main content

Table 2 Number of patients who were exposed to statins and other lipid lowering agents

From: Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea

Medication Number (%) of patients who had exposure to medication Cumulative duration (years) of exposure to medication
Any statin 96,182 (25.3) 165,083
 Atorvastatin 61,157 (16.1) 78,627
 Rosuvastatin 11,720 (3.1) 14,678
 Pitavastatin 8010 (2.1) 7691
 Pravastatin 8047 (2.1) 8099
 Simvastatin 46,773 (12.3) 46,768
 Lovastatin 9291 (2.4) 6045
 Fluvastatin 3786 (1.0) 3175
Fibratea 14,926 (3.9) 11,617
Ezetimibe 5847 (1.5) 5830
  1. Data are based on time period between baseline and last health examination of each subject
  2. aBezafibrate, ciprofibrate, etofibrate, fenofibrate, and gemfibrozil